Health Care Archives - Page 22 of 478

1 minute read

DNA Medicine Focused INOVIO Pharma Efficiencies Implemented By Leadership Will Help De-Risk Its Platform Technology: Analyst

May 14, 2:37 PM

Stephens covers INOVIO Pharmaceuticals highlighting its diverse clinical pipeline and FDA's consideration of INO-3107 Phase 1/2 trials for Accelerated Approval. Potential as the first non-surgical RRP treatment.

INO

1 minute read

Indian Rival Meril Accuses Edwards Lifesciences Of Anti-Competitive Behavior In EU Antitrust Complaint

By Vandana Singh

May 14, 2:33 PM

Edwards Lifesciences faces EU antitrust complaint from Meril over patent disputes, intensifying regulatory scrutiny. Recent actions aim to ensure fair competition, affordability, as Meril alleges patent abuses and obstruction to innovation.

2 minute read

Philips Sues SoClean Alleging Ozone Exposure Risks Over Injuries Related To Breathing Devices

By Vandana Singh

May 14, 1:44 PM

Legal battle ensues between Philips and SoClean post $1.1 billion settlement over CPAP device recall. Lawsuit alleges SoClean's ozone exposure led to injuries. Philips targets DWHP, alleging SoClean as an "alter ego." FDA warns against ozone cleaners.

PHG

2 minute read

Pliant Therapeutics’ Drug Trial Shows Promise In Reversing Lung Fibrosis In Patients

By Vandana Singh

May 14, 10:39 AM

Phase 2a trial results of Pliant Therapeutics' bexotegrast (PLN-74809) for idiopathic pulmonary fibrosis. Reduced lung collagen, improved FVC, and cough severity, signaling potential fibrosis reversal.

PLRX

2 minute read

FDA Declines To Approve Expanded Use of Dynavax’s Hepatitis B Vaccine In Hemodialysis Patients

By Vandana Singh

May 14, 10:10 AM

Latest regulatory update from Dynavax on HEPLISAV-B vaccine regimen for adults on hemodialysis, with FDA's Complete Response Letter.

DVAX

2 minute read

Novo Nordisk’s Wegovy Delivers: Long-Term Study Shows Sustained Weight Loss As Drugmaker Tries To Woo Insurers And Governments

By Benzinga Neuro

May 14, 2:26 AM

The data could potentially bolster Novo's case for Wegovy as it attempts to convince insurers and governments to cover the cost of the drug.

NONOF

2 minute read

Vaxart Stock Climbs After Blockbuster Q1 Revenue

By Erica Kollmann

May 13, 4:29 PM

Vaxart reported quarterly losses of 14 cents per share, inline with the analyst consensus estimate. Quarterly sales clocked in at $2.181 million, beating the analyst consensus estimate of $800,000 by 172.63% and representing a 223.11% increase over sales of $675,000 from the same period last year.

VXRT

1 minute read

Johnson & Johnson’s Subsidiary Discontinues Some Megadyne Electrodes For Pediatric Use

By Vandana Singh

May 13, 2:30 PM

Johnson & Johnson's Megadyne Mega Soft Pediatric Patient Return Electrodes recalled due to patient burns. FDA's Class I recall impacts 21,200 devices.

JNJ

2 minute read

Why Is Inventiva’s Stock Trading Higher on Monday?

By Vandana Singh

May 13, 2:08 PM

Inventiva's Lanifibranor improves cardiometabolic health in MASH/NASH patients. It lowers fasting glucose, reduces cardiovascular risk, and increases adiponectin levels. Weight gain correlates with health improvement.

IVA

2 minute read

Novo Nordisk’s Hemophilia Candidate Can Prevent Bleeding Episodes Effectively, Regardless Of Dosing Frequency

By Vandana Singh

May 13, 2:06 PM

Novo Nordisk's Phase 3a trial demonstrates a significant reduction in bleeding episodes with Mim8 treatment for hemophilia A patients. Superior efficacy and safety profile revealed.

NVO